National Malaria Elimination Program (NMEP) National Coordinator, Dr. Perpetual Uhomoibhi, has said the End Malaria Council currently has a funding gap of 48 to 50 percent to implement its 2021-2025 strategic plan in Nigeria.

Uhomoibhi stated this at the biweekly ministerial meeting on the update on the response and development of COVID-19 in the country’s health sector.

End Malaria Council is a presidential directive created to end malaria in accordance with the African Union mandate.


The council consists of a public-private partnership that aims to ensure that malaria remains high on the political agenda of the country, both at the federal and local government level.

It is also intended as a council to provide advocacy to various levels of government such as the legislature, governors, and also to mobilize resources to fill the gap and implementation of the malaria program.

According to Uhomoibhi, “Right now looking at the strategic plan from 2021 to 2025, we have a funding gap of about 48 to about 50 percent, funding shortfalls.

Read also:  Creative market stimulates export of talent

“So to ensure that all interventions are covered, we need additional resources beyond what the government and partners have provided.

“We have identified some key private sector CEOs who will help us mobilize additional cash and kind resources and the chairman of the board is Alhaji Dangote, the president and CEO of the Dangote group and we have members of the National Assembly, the Senate Committee on Health Chair, and also the House Committee on Tuberculosis and Malaria, as well as the Governor’s Forum Chair, other private sectors and religious group leaders to be the members of the Council.

“So far, the president himself has inaugurated the council and the inaugural meeting is being planned by the National Malaria Program in conjunction with the council chairman.”

The coordinator also revealed that outside the council, the national program is also implementing seasonal malaria chemotherapy in 21 states of the country.

She said: “This is a significant increase from 9 states in the year 2000 and this year for the first time we cover all eligible states, including the Federal Capital Territory.

Read also:  Male Bauchi Students Protest Separation From Their Female Friends in High Schools

“Seasonal malaria chemoprevention is the administration of the antimalarial drug to children at the age of 5, just before the start of the rainy season in more than 4 to 5 cycles per month to ensure that children who are most vulnerable in terms of severe malaria and death are protected during the rainy seasons, together with our partners we are implementing it in 21 states this year.”

“Together with the primary health care development agency, we are developing a concept note and an expression of interest for us to have access to that vaccine when it becomes available to other countries outside those three countries and it is one for children as young as 5 years and not for children. adults . The RTSSAS01 that is available is intended for children only.” She added.

Leave a Reply

Your email address will not be published.